CIK 0001725160 · Non-accelerated filer<br>Smaller reporting company
Zentalis Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ZNTL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 823607803
- Phone
- (858) 263-4333
- Business address
- 10275 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- Zentalis Pharmaceuticals, LLC, Zeno Pharma, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-30 | Bruns Ingmar Chief Medical Officer | Grant or award | +9,727 | $2.18 | $21K | 43,059 |
| 2026-08-14 | WALTERS GROUP 10% owner | Purchase | +4,335,000 | $3.50 | $15.2M | 17,844,973 |
| 2026-06-16 | Kariuki Enoch Director | Grant or award | +57,100 | 194,465 | ||
| 2026-06-16 | Skvarka Jan Director | Grant or award | +57,100 | 264,254 | ||
| 2026-06-16 | Johnson David Michael Director | Grant or award | +57,100 | 307,521 | ||
| 2026-06-16 | Walker Luke Nathaniel Director | Grant or award | +57,100 | 201,384 | ||
| 2026-06-16 | Myers Scott Dunseth Director | Grant or award | +57,100 | 395,895 | ||
| 2026-05-26 | Campbell Shannon Director | Grant or award | +114,200 | 114,200 | ||
| 2026-02-10 | Vultaggio Vincent PAO and PFO | Sale 10b5-1 | −6,894 | $2.42 | $17K | 146,506 |
| 2026-02-09 | Vultaggio Vincent PAO and PFO | Sale 10b5-1 | −3,379 | $2.39 | $8K | 153,400 |
| 2026-02-09 | Bruns Ingmar Chief Medical Officer | Sale | −335 | $2.39 | $802 | 33,332 |
| 2026-02-09 | EASTLAND JULIA MARIE CEO & President | Sale | −889 | $2.39 | $2K | 79,133 |
| 2026-02-06 | Vultaggio Vincent PAO and PFO | Sale 10b5-1 | −29,951 | $2.43 | $73K | 156,779 |
| 2026-02-06 | Bruns Ingmar Chief Medical Officer | Sale | −2,962 | $2.43 | $7K | 33,667 |
| 2026-02-06 | EASTLAND JULIA MARIE CEO & President | Sale | −7,866 | $2.43 | $19K | 80,022 |
| 2026-02-03 | Vultaggio Vincent PAO and PFO | Sale 10b5-1 | −556 | $2.52 | $1K | 186,730 |
| 2026-02-02 | Vultaggio Vincent PAO and PFO | Sale 10b5-1 | −2,540 | $2.55 | $6K | 187,286 |
| 2026-01-08 | Vultaggio Vincent PAO and PFO | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2026-01-08 | Bruns Ingmar Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +365,000 | 365,000 | ||
| 2026-01-08 | Bucher James B Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 |
Page 1 of 8 · 160 trades